|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Expression of FHIT (quick score 98.7 vs. 206.4) and p27 (QS 187.3 vs. 244.8) was significantly lower in carcinomas compared to non-tumor control tissue.
|
30673867 |
2019 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
HDAC2 protein was positively correlated USP5 protein, and negatively correlated with p27 protein in ovarian serous carcinomas tissues.
|
31727867 |
2019 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Altogether, our data suggests that p27 and its cognate ubiquitin ligases are specifically involved in the clinical profiles, and thus, molecular targeting of these ubiquitin ligases, in particular, Pirh2, may have therapeutic value for human lung carcinomas.
|
28601655 |
2017 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
P21 and p27 Immunoexpression in Upper Urinary Tract Urothelial Carcinomas.
|
27222134 |
2016 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
The aim of this study was to investigate the relationship between different human papillomavirus (HPV) genotypes and the expression of p53, p21 and p27 in cervical carcinomas.
|
19657726 |
2010 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Moreover, GPR48 expression was significantly associated with lymph node metastasis and inversely correlated with p27 expression in human colon carcinomas.
|
17178856 |
2006 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The expression of the cell-cycle proteins cyclins A, B1 and E and SKP2 is associated with a BRCA1 phenotype, whereas cyclin D1 and p27 expression is associated with BRCA2 carcinomas.
|
15933754 |
2005 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Expression of Skp2 showed an inverse topographic distribution and correlation to that of p27 in many esophageal carcinomas.
|
15161026 |
2004 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Mice with reduced p27 gene dosage alone do not develop mammary carcinomas but do display substantially shorter tumor latency upon overexpression of erbB2, consistent with a role for p27 as a mammary tumor suppressor gene.
|
15082918 |
2004 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
These findings indicate that Cks1, as well as Skp2, regulates the expression level of p27 protein in gastric carcinomas.
|
14654553 |
2003 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
High Ki-67 proliferative index was seen in 2% of adenomas and 25% of carcinomas, whereas p27 expression was present in 80% of adenomas and 18% of carcinomas.
|
12605367 |
2003 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
High p27 levels (p27 LI, > 50%) were observed in 14 (26.9%) of 52 carcinomas and were significantly associated with metastatic disease in axillary lymph nodes (14 of 33 vs. 0 of 19; P = 0.0007 by Fisher exact test).
|
12015771 |
2002 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Nuclear P-p27 protein levels were significantly decreased in the adenomas, compared with the normals, and were much lower in the carcinomas, compared with either normal pituitary tissue or pituitary adenomas.
|
12050228 |
2002 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Positive p27 staining rates were significantly higher in serous adenomas (p=0.006) and in serous LMP tumors (p=0.013) than that in serous carcinomas (Fisher's exact test).
|
11295040 |
2001 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Skp2 protein overexpression may lead to accelerated p27 proteolysis and contribute to malignant progression from dysplasia to oral epithelial carcinoma.
|
11309491 |
2001 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Loss of p27 protein provides independent prognostic information in breast, prostate, colon, and gastric carcinomas, and immunohistochemical (IHC) staining for p27 may eventually become part of routine histopathologic processing of cancers.
|
10073286 |
1999 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Low levels of p27 are associated with poor prognosis in a variety of tumors, including breast, colon, prostate, and lung carcinomas.
|
10446997 |
1999 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Although genetic changes of p27/kip1 are extremely rare, in many human carcinomas p27 levels are reduced, correlate with histological malignancy, and are associated with poor prognosis.
|
10603039 |
1999 |
|
Carcinoma
|
0.100 |
Biomarker
|
group |
BEFREE |
Levels of p27 have been found to have independent prognostic significance in a variety of tumors including breast, colon, prostate, ovary, and gastric carcinomas.
|
9973218 |
1999 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In contrast to BPH, prostate carcinomas were found to contain abundant p27KIP1 mRNA but either high or low to undetectable levels of p27 protein.
|
9731735 |
1998 |
|
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We found that carcinomas with low or absent p27 protein displayed enhanced proteolytic activity specific for p27, suggesting that low p27 expression can result from increased proteasome-mediated degradation rather than altered gene expression.
|
9018245 |
1997 |